tradmap

MGRX MANGOCEUTICALS, INC.

$0.23 -2.51%

Data as of close

Healthcare · Services-Misc Health & Allied Services, Nec

MANGOCEUTICALS, INC. (MGRX) is a healthcare company in the Services-Misc Health & Allied Services, Nec industry, with a market capitalization of $5 million. Shares last traded at $0.23, 91.5% below their 52-week high. Over the past year the stock is down 88.8%. Revenue declined 26.0% year over year.

Market Cap
$5M
Shares Out
21.6M
EPS (TTM)
-$0.79
P/E (TTM)*
—
P/S Ratio
15.66
P/B Ratio
0.39
Dividend / Share
—
Dividend Yield
—
52-Week High
$2.70
52-Week Low
$0.22
Volume (venue)
11,245
Avg Vol (3m, venue)
44,057.016

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Performance

1W
-3.58%
1M
-47.29%
3M
-50.13%
6M
-32.93%
YTD
-68.21%
1Y
-88.83%

Daily candles · volume · SMA(20)/SMA(50) · split-adjusted · Databento EQUS.MINI. MGRX split history →

Technicals

RSI (14)
31.64
SMA (50)
$0.38
SMA (200)
$0.41
Price vs SMA50
-39.07%
Price vs SMA200
-44.32%
ATR (14)
$0.03

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$315227
Net Income
-$15M
Gross Margin
54.4%
Operating Margin
—
Net Margin
—
Return on Equity
-120.6%
Return on Assets
-106.6%
Current Ratio
0.18
Debt / Equity
0.13
Revenue Growth (YoY)
-26.0%

Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-06-30. Source: SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q2 2026 -$0.09 2026-08-13
Q1 2026 -$0.22 2026-05-19
Q4 2025 (derived) $0.21 2026-04-01
FY 2025 -$2.17 2026-04-01
Q3 2025 -$0.69 2025-11-14
Q2 2025 -$0.57 2025-08-14

Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.

Full earnings history →

Services-Misc Health & Allied Services, Nec peers

MGRX vs 11 industry peers (Services-Misc Health & Allied Services, Nec), by market cap. Data as of close

P/S vs peers
15.66 / 1.55 med
+908% premium
1–11 of 11
DVADaVita$11.7B12.700.826.5%-1.02%
SHCSotera Health Co$5.1B30.934.1613.4%-2.26%
PGNYProgyny, Inc.$2.3B28.711.726.0%+0.72%
AGLAgilon Health, Inc.$1.5B—0.25-3.9%+2.46%
VMDVIEMED HEALTHCARE, INC.$360M24.801.194.8%-2.48%
PARKPark Dental Partners, Inc.$100M———-0.54%
CCELCRYO CELL INTERNATIONAL INC$43M—1.39-6.2%+3.38%
MGRXMANGOCEUTICALS, INC.$5M—15.66—-2.51%
BRTXBioRestorative Therapies, Inc.$2M—5.34—+6.38%
NIVFNewGenIvf Group Ltd————-7.75%
FMSFresenius Medical Care Ag————+0.67%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.